• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT HBSAG REAGENT KIT; TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM) Back to Search Results
Catalog Number 06C36-76
Device Problem False Negative Result (1225)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/06/2021
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.This report is being filed on an international product, list number 6c36 that has a similar product distributed in the us, list number 4p53.
 
Event Description
The customer reported a (b)(6) architect (b)(6) result for a patient.The following data was provided on (b)(6) 2021: elisa method = initial result = (b)(6).Autobio instrument result = (b)(6).Architect i2000sr analyzer initial result =(b)(6), repeat after centrifugation = (b)(6).There was no impact to patient management reported.
 
Manufacturer Narrative
The complaint investigation for potential false negative architect hbsag results included a search for similar complaints, and review of complaint text, trending data, labeling, and device history records.In-house testing of the complaint lot was completed.Return testing was not completed as returns were not available.Trending review determined no trends were identified for the issue for the product.Device history record review for the complaint lot did not show any non-conformances or deviations.In house testing of sensitivity panels which mimic patient samples was completed using retained samples of the complaint lot.All specifications were met indicating that the lot is performing acceptably.Labeling was reviewed and found to adequately address the issue under review.Based on the investigation, no systemic issue or deficiency of the architect hbsag assay, lot number 14116fn01 was identified.Corrected information: d.Suspect medical device: d4: lot number: old lot 14116fn00 to new lot 14116fn01.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HBSAG REAGENT KIT
Type of Device
TEST, HEPATITIS B (B CORE, BE ANTIGEN, BE ANTIBODY, B CORE IGM)
Manufacturer (Section D)
ABBOTT IRELAND
finisklin business park
sligo F91VY 44
EI  F91VY44
MDR Report Key11174398
MDR Text Key235045954
Report Number3008344661-2021-00011
Device Sequence Number1
Product Code LOM
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 02/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/14/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/18/2021
Device Catalogue Number06C36-76
Device Lot Number14116FN01
Was Device Available for Evaluation? No
Date Manufacturer Received02/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARC I2000SR INST, 03M74-02, (B)(6) ; ARC I2000SR INST, 03M74-02, (B)(6)
-
-